Improving COVID-19 vaccine uptake: a message co-design process for a national mHealth intervention in Colombia.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101496665 Publication Model: Print Cited Medium: Internet ISSN: 1654-9880 (Electronic) Linking ISSN: 16549880 NLM ISO Abbreviation: Glob Health Action Subsets: MEDLINE

Publication: <2016- > : Philadelphia, PA : Taylor & Francis
Original Publication: Häggeby : Co-Action Publishing

COVID-19 Vaccines*/therapeutic use ; COVID-19*/prevention & control; Adult ; Humans ; Colombia ; Health Priorities ; Interdisciplinary Studies

Background: COVID-19 vaccination is a global priority. Latin American countries have some of the highest COVID-19 death rates worldwide with vaccination hampered by a variety of reasons, including mis- and disinformation, vaccine hesitancy, and vaccine supply constraints. Addressing vaccine hesitancy through effective messages has been found to help increase vaccine uptake. Participatory processes could be used to co-design health messages for this purpose.
Objective: This article describes the methodology used to co-design evidence-based audio messages to be deployed in a cohort of individuals through an interactive voice response (IVR) mobile phone survey intervention, aimed towards increasing vaccination uptake in an adult population in Colombia.
Methods: Participants of the COVID-19 vaccination message co-design process included a sample of the general population of the country, representatives of the funder organisation, and research team members. The co-design process consisted of four phases: (1) formative quantitative and qualitative research, (2) message drafting based on the results of the formative research, (3) message content evaluation, and (4) evaluation of the voices to deliver the audio messages; and was informed by reflexive meetings.
Results: Three categories of evidence-based audio messages were co-designed, each corresponding to an arm of the mHealth intervention: (1) factual messages, (2) narrative messages, and (3) mixed messages. An additional fourth arm with no message was proposed for control. The iterative co-design process ended with a total of 14 audio messages recorded to be deployed via the intervention.
Conclusions: Co-developing health messages in response to health emergencies is possible. Adopting more context-relevant, participatory, people-centred, and reflexive multidisciplinary approaches could help develop solutions that are more responsive to the needs of populations and public health priorities. Investing resources in message co-design is deemed to have a greater potential for influencing behaviours and improving health outcomes.

Int J Environ Res Public Health. 2020 Aug 13;17(16):. (PMID: 32823775)
Emerg Infect Dis. 2020 Dec;26(12):2854-2862. (PMID: 33219646)
Vaccines (Basel). 2022 Apr 04;10(4):. (PMID: 35455307)
Health Promot Pract. 2022 Jan;23(1):46-50. (PMID: 34672826)
Curr Opin Psychol. 2015 Oct;5:78-84. (PMID: 26213711)
Glob Health Action. 2020 Dec 31;13(1):1754016. (PMID: 32406330)
Vaccine. 2018 Mar 7;36(11):1509-1515. (PMID: 29287678)
Nat Commun. 2022 Jul 1;13(1):3801. (PMID: 35778396)
Disaster Med Public Health Prep. 2013 Aug;7(4):424-30. (PMID: 24229528)
Health Commun. 2022 Nov;37(12):1465-1475. (PMID: 35164624)
JMIR Form Res. 2020 Dec 3;4(12):e21671. (PMID: 33270037)
Lancet Psychiatry. 2021 Jun;8(6):535-550. (PMID: 33639109)
Lancet Psychiatry. 2020 May;7(5):381-383. (PMID: 32353264)
J Public Health Policy. 2020 Dec;41(4):410-420. (PMID: 32826935)
Lancet Glob Health. 2019 Mar;7(3):e303-e304. (PMID: 30784627)
Vaccines (Basel). 2021 Jan 20;9(2):. (PMID: 33498395)
J Affect Disord. 2021 Dec 1;295:1335-1346. (PMID: 34706447)
PLoS One. 2021 Mar 4;16(3):e0246987. (PMID: 33661926)
Am J Trop Med Hyg. 2020 Nov;103(5):1765-1772. (PMID: 32940204)
Popul Health Metr. 2021 Jun 28;19(1):32. (PMID: 34183013)
PLoS One. 2021 Oct 28;16(10):e0259059. (PMID: 34710168)
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e20356. (PMID: 32955455)
Travel Med Infect Dis. 2022 Sep-Oct;49:102369. (PMID: 35680058)
Front Psychol. 2022 Mar 28;13:760146. (PMID: 35418898)
Brain Behav Immun. 2022 Mar;101:93-135. (PMID: 34973396)
PLOS Glob Public Health. 2022 Aug 16;2(8):e0000918. (PMID: 36962801)
BMJ Glob Health. 2018 Nov 16;3(6):e001183. (PMID: 30498592)
Vaccine. 2015 Aug 14;33(34):4204-11. (PMID: 25900132)
Vaccine. 2023 Jan 9;41(2):354-364. (PMID: 36414475)
Health Policy Technol. 2022 Jun;11(2):100621. (PMID: 35340774)
BMJ. 2021 Feb 15;372:m4785. (PMID: 33593804)
Telemat Inform. 2021 Dec;65:101712. (PMID: 34887618)
Glob Health Promot. 2019 Mar;26(1):33-40. (PMID: 28353393)
Implement Sci. 2011 Apr 23;6:42. (PMID: 21513547)
Behav Res Methods Instrum Comput. 2002 Aug;34(3):342-53. (PMID: 12395550)
Lancet. 2008 Nov 8;372(9650):1661-9. (PMID: 18994664)
J Health Commun. 2013;18(1):20-40. (PMID: 22934539)
Health Res Policy Syst. 2022 Mar 5;20(1):28. (PMID: 35248064)
Vaccine. 2015 Aug 14;33(34):4212-4. (PMID: 25896382)
Wellcome Open Res. 2021 Jan 29;6:17. (PMID: 33693063)
Int J Telemed Appl. 2013;2013:482324. (PMID: 24369460)
Health Commun. 2013;28(2):133-45. (PMID: 22452627)
Lancet Healthy Longev. 2022 Apr;3(4):e242-e252. (PMID: 35340743)
Health Commun. 2012;27(5):413-20. (PMID: 21957983)

Keywords: COVID-19 vaccination; Co-design; behavior change; intervention development; message design

0 (COVID-19 Vaccines)

Date Created: 20230829 Date Completed: 20230831 Latest Revision: 20230912

20240514

PMC10467523

10.1080/16549716.2023.2242670

37643136